TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer Patients

por Fariña-Sarasqueta, A., Gosens, M. J. E. M., Moerland, E., van Lijnschoten, I., Lemmens, V. E. P. P., Slooter, G. D., Rutten, H. J. T., van den Brule, A. J. C.
Publicado 2010